4//SEC Filing
LINDSTROM RICHARD L MD 4
Accession 0001493152-22-027463
CIK 0001360214other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 6:02 PM ET
Size
6.5 KB
Accession
0001493152-22-027463
Insider Transaction Report
Form 4
LINDSTROM RICHARD L MD
Director
Transactions
- Sale
Common Stock
2022-09-30$12.62/sh−40,000$504,800→ 26,100 total(indirect: See Footnote)
Holdings
- 100,000
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a predetermined Rule 10b5-1 trading plan adopted by the reporting person during December 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.03 to $12.50, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. ("Harrow"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Represents shares held by the Lindstrom Family Limited Partnership No 2, a limited partnership of which the reporting person is the 100% owner and sole general partner.
Documents
Issuer
HARROW HEALTH, INC.
CIK 0001360214
Entity typeother
Related Parties
1- filerCIK 0001242177
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 6:02 PM ET
- Size
- 6.5 KB